Maternal and paternal thrombophilia: Risk factors for perinatal mortality

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 3, 2005, Pages 306-311

  De Galan Roosen, Agnes E M ^a   Kuijpers, Johan C ^b   Rosendaal, Frits R ^c   Steegers, Eric A ^d   Van Beers, Wil A ^b   Ponjee, Gabriëlle A ^b   Merkus, Hans M ^e  

^a CPRLab   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; HOMOCYSTEINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTEIN S; PROTHROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CONGENITAL MALFORMATION; CONTROLLED STUDY; DENMARK; ENZYME LINKED IMMUNOSORBENT ASSAY; FATHER; FEMALE; GENE MUTATION; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; MOTHER; ORAL CONTRACEPTION; PERINATAL MORTALITY; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTITHROMBINS; EPIDEMIOLOGIC METHODS; FACTOR V; FACTOR VIII; FATHERS; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MOTHERS; MUTATION; NETHERLANDS; PEDIGREE; PREGNANCY; THROMBOPHILIA;

EID: 14644424565     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00435.x     Document Type: Article

References (27)

1. Richardus JH, Graafmans WC, van der Pal-de Bruin KM, Amelink-Verburg MP, Verloove-Vanhorick SP, Mackenbach JP. An European concerted action investigating the validity of perinatal mortality as an outcome indicator for the quality of antenatal and perinatal care. J Perinat Med 1997;25(4):313-324.
2. Girling J, de Swiet M. Inherited thrombophilia and pregnancy. Curr Opin Obstet Gynecol 1998;10(2):135-144.
3. Vries JIPd, Dekker GA, Huijgens PC, Jakobs C, Blomberg BMEv, Geijn HPv. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997;104:1248-1254.
4. Wouters MGAJ, Boers GHJ, Blom HJ, et al. Hyperhomocysteinaemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820-825.
5. Nelen WLDM, Molen EF van der, Blom HJ, Heil SG, Steegers EAP, Eskes TKAB. Recurrent early pregnancy loss and genetic-related disturbances in folate and homocysteine metabolism. Lancet 1997;350:861.
6. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999;82(1):6-9.
7. Foka ZJ, Lambropoulos AF, Saravelos H, et al. Factor V Leiden and Prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 2000;15(2):458-462.
8. Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern-Fetal Med 1998;7(6):277-286.
9. Gris JC, Quere I, Monpeyroux F, et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent-the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost 1999;81(6):891-899.
10. Martinelli I, Taioli E, Cetin I, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343(14): 1015-1018.
11. Kupfermine MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
12. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348(9032):913-916.
13. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998;316(7141):1343-1347.
14. Galan-Roosen AE, Kuijpers JC, Straaten PJCvd, Merkus JMWM. Evaluation of 239 cases of perinatal death: using a fundamental classification system. Eur J Obstet Gynecol Reprod Biol 2002;103:37-42.
15. WHO. International Classification of Diseases, 10th edition. Geneva: WHO, 1992.
16. Galan-Roosen AE, Kuijpers JC, Oei YB, van Velzen D, Mackenbach JP. Discrepancy between results of registration of perinatal cause of death by the CBS (Central Bureau of Statistics) and by personal studies in the Delft-Westland-Oostland region. Ned Tijdschr Geneeskd 1997;141(5):237-240.
17. Leyte A, Smits PH, van Straalen JP, van Doom LJ, Quint WG. Automated, simultaneous detection of the factor V Leiden and prothrombin (G20210A) variants using multiplex PCR and a line probe assay. Thromb Haemost 2000;83(2):354-355.
18. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-253.
19. Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001;344(12):867-872.
20. Zusterzeel PLM. Biotransformation enzymes and oxidative stress in preeclampsia. Thesis, Catholic University Nijmegen, 2001.
21. Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-405.
22. Thorarensen O, Ryan S, Hunter J, Younkin DP, Factor V. Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neurol 1997;42(3):372-375.
23. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996;87(9):3531-3544.
24. Kamphuisen PW, Lensen R, Houwing-Duistermaat JJ, et al. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. Br J Haematol 2000;109(3):519-522.
25. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000;53(8): 573-580.
26. De Walle HE, de Jong-van den Berg LT, Cornel MC. Periconceptional folic acid intake in the northern Netherlands. Lancet 1999;353(9159):1187.
27. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314(7076):253-257.